β-Lactams Increase the Antibacterial Activity of Daptomycin against Clinical Methicillin-Resistant Staphylococcus aureus Strains and Prevent Selection of Daptomycin-Resistant Derivatives

Ampicillin Enhances Daptomycin- and Cationic Host Defense Peptide-Mediated Killing of Ampicillin- and Vancomycin-Resistant Enterococcus faecium

(2011) George Sakoulas et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

VraSR Two-Component Regulatory System Contributes tomprF-Mediated Decreased Susceptibility to Daptomycin inIn Vivo-Selected Clinical Strains of Methicillin-Resistant Staphylococcus aureus

(2011) Shrenik Mehta et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Use of Antistaphylococcal  -Lactams to Increase Daptomycin Activity in Eradicating Persistent Bacteremia Due to Methicillin-Resistant Staphylococcus aureus: Role of Enhanced Daptomycin Binding

(2011) A. Dhand et al.   CLINICAL INFECTIOUS DISEASES

Clinical Practice Guidelines by the Infectious Diseases Society of America for the Treatment of Methicillin-Resistant Staphylococcus aureus Infections in Adults and Children: Executive Summary

(2011) Catherine Liu et al.   CLINICAL INFECTIOUS DISEASES

Wax moth larva (Galleria mellonella): an in vivo model for assessing the efficacy of antistaphylococcal agents

(2011) A. P. Desbois et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Evolution of Multidrug Resistance during Staphylococcus aureus Infection Involves Mutation of the Essential Two Component Regulator WalKR

(2011) Benjamin P. Howden et al.   PLoS Pathogens

Novel Daptomycin Combinations against Daptomycin-Nonsusceptible Methicillin-Resistant Staphylococcus aureus in an In Vitro Model of Simulated Endocardial Vegetations

(2010) M. E. Steed et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Daptomycin-Oxacillin Combinations in Treatment of Experimental Endocarditis Caused by Daptomycin-Nonsusceptible Strains of Methicillin-Resistant Staphylococcus aureus with Evolving Oxacillin Susceptibility (the "Seesaw Effect")

(2010) S.-J. Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Carotenoid-Related Alteration of Cell Membrane Fluidity ImpactsStaphylococcus aureusSusceptibility to Host Defense Peptides

(2010) Nagendra N. Mishra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Cell Wall Thickening Is Not a Universal Accompaniment of the Daptomycin Nonsusceptibility Phenotype in Staphylococcus aureus: Evidence for Multiple Resistance Mechanisms

(2010) S.-J. Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

In vitro prevention of the emergence of daptomycin resistance in Staphylococcus aureus and enterococci following combination with amoxicillin/clavulanic acid or ampicillin

(2010) José M. Entenza et al.   INTERNATIONAL JOURNAL OF ANTIMICROBIAL AGENTS

Regulation of mprF in Daptomycin-Nonsusceptible Staphylococcus aureus Strains

(2009) S.-J. Yang et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Analysis of Cell Membrane Characteristics of In Vitro-Selected Daptomycin-Resistant Strains of Methicillin-Resistant Staphylococcus aureus

(2009) N. N. Mishra et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Galleria mellonella as a Model System To Study Acinetobacter baumannii Pathogenesis and Therapeutics

(2009) A. Y. Peleg et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Daptomycin: mechanisms of action and resistance, and biosynthetic engineering

(2009) Richard H Baltz   CURRENT OPINION IN CHEMICAL BIOLOGY

Development of homogeneous expression of resistance in methicillin-resistant Staphylococcus aureus clinical strains is functionally associated with a β-lactam-mediated SOS response

(2009) Arabela Cuirolo et al.   JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY

Unusual form of oxacillin resistance in methicillin-resistant Staphylococcus aureus clinical strains

(2008) Betty A. Forbes et al.   DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE